These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 27815022)
41. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis. Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029 [TBL] [Abstract][Full Text] [Related]
42. Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics. Gioanni Y; Thierry AM; Glowinski J; Tassin JP Synapse; 1998 Dec; 30(4):362-70. PubMed ID: 9826228 [TBL] [Abstract][Full Text] [Related]
43. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways. Sakai K; Gao XM; Hashimoto T; Tamminga CA Synapse; 2001 Feb; 39(2):152-60. PubMed ID: 11180502 [TBL] [Abstract][Full Text] [Related]
44. Changes in [ Rosin C; López Ordieres MG; Rodríguez de Lores Arnaiz G Peptides; 2017 Mar; 89():82-89. PubMed ID: 27586561 [TBL] [Abstract][Full Text] [Related]
45. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049 [TBL] [Abstract][Full Text] [Related]
46. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus. Bermack JE; Debonnel G Synapse; 2005 Jan; 55(1):37-44. PubMed ID: 15499608 [TBL] [Abstract][Full Text] [Related]
47. Dopamine on D2-like receptors "reboosts" dopamine D1-like receptor-mediated behavioural activation in rats licking for sucrose. D'Aquila PS Neuropharmacology; 2010 Jun; 58(7):1085-96. PubMed ID: 20149807 [TBL] [Abstract][Full Text] [Related]
48. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release. Broderick PA; Piercey MF J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116 [TBL] [Abstract][Full Text] [Related]
49. Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain. Chong VZ; Skoblenick K; Morin F; Xu Y; Mishra RK Neuroscience; 2006; 138(2):587-99. PubMed ID: 16413126 [TBL] [Abstract][Full Text] [Related]
50. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models. Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908 [TBL] [Abstract][Full Text] [Related]
51. Functional interplay between ganglioside GM1 and cross-linking galectin-1 induces axon-like neuritogenesis via integrin-based signaling and TRPC5-dependent Ca²⁺ influx. Wu G; Lu ZH; André S; Gabius HJ; Ledeen RW J Neurochem; 2016 Feb; 136(3):550-63. PubMed ID: 26526326 [TBL] [Abstract][Full Text] [Related]
52. The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats. Toua C; Brand L; Möller M; Emsley RA; Harvey BH Neuroscience; 2010 Jan; 165(2):492-9. PubMed ID: 19854242 [TBL] [Abstract][Full Text] [Related]
53. Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear. Inoue T; Izumi T; Li XB; Kitaichi Y; Nakagawa S; Koyama T Eur J Pharmacol; 2005 Sep; 519(3):253-8. PubMed ID: 16135362 [TBL] [Abstract][Full Text] [Related]
54. Neuro-anatomic mapping of dopamine D1 receptor involvement in nicotine self-administration in rats. Hall BJ; Slade S; Allenby C; Kutlu MG; Levin ED Neuropharmacology; 2015 Dec; 99():689-95. PubMed ID: 25797492 [TBL] [Abstract][Full Text] [Related]
55. Haloperidol Prevents Oxytosis/Ferroptosis by Targeting Lysosomal Ferrous Ions in a Manner Independent of Dopamine D2 and Sigma-1 Receptors. Hirata Y; Oka K; Yamamoto S; Watanabe H; Oh-Hashi K; Hirayama T; Nagasawa H; Takemori H; Furuta K ACS Chem Neurosci; 2022 Sep; 13(18):2719-2727. PubMed ID: 36050287 [TBL] [Abstract][Full Text] [Related]
56. Cortical cell plasma membrane alterations after in vitro alcohol exposure: prevention by GM1 ganglioside. Laev H; Hungund BL; Karpiak SE Alcohol; 1996; 13(2):187-94. PubMed ID: 8814655 [TBL] [Abstract][Full Text] [Related]
57. Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism. Finsterwald C; Dias S; Magistretti PJ; Lengacher S Front Pharmacol; 2021; 12():653842. PubMed ID: 33995070 [TBL] [Abstract][Full Text] [Related]
58. Haloperidol-associated stealth liposomes: a potent carrier for delivering genes to human breast cancer cells. Mukherjee A; Prasad TK; Rao NM; Banerjee R J Biol Chem; 2005 Apr; 280(16):15619-27. PubMed ID: 15695518 [TBL] [Abstract][Full Text] [Related]
60. An in vitro study on increased neuronal and astrocytic vulnerability to neurotoxic injury after in utero cocaine exposure: the reversal effects of GM1 treatment. Stadlin A; Tsang D; MacDonall JS; Mahadik SP; Karpiak SE Prog Brain Res; 1992; 94():339-50. PubMed ID: 1363146 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]